Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Array technology and proteomics in autoimmune diseases.

Veit Krenn1, Iver Petersen, Thomas Häupl

  • 1Department of Pathology, Universitätsklinikum Charité, Schumannstrasse 20121, Berlin 10117, Germany. veit.krenn@charite.de

Pathology, Research and Practice
|July 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and clinico-morphological correlates of STK11 mutations in a large cohort of NSCLC lung adenocarcinomas.

Virchows Archiv : an international journal of pathology·2026
Same author

Presence and reactivities of antibodies directed to citrullinated peptides in a Swedish JIA cohort.

Pediatric rheumatology online journal·2025
Same author

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

medRxiv : the preprint server for health sciences·2025
Same author

In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation.

Annals of the rheumatic diseases·2023
Same author

Pathologie (Heidelberg, Germany)·2023
Same author

[Testing deficient mismatch repair and microsatellite instability : A focused update. German version].

Pathologie (Heidelberg, Germany)·2023

Tissue microarrays (TMAs) and proteomics generate vast life science data. Their combination advances autoimmune disease research, enabling new diagnostic tools and antigen-specific therapies.

Area of Science:

  • Life Science
  • Biotechnology
  • Immunology

Background:

  • Tissue microarrays (TMAs) enable large-scale, standardized analysis of proteins and RNA.
  • Proteomics offers high-throughput techniques for protein characterization, function, and immunologic reactivity.
  • Integrating proteomics with TMAs is crucial for validating protein findings at the tissue level.

Purpose of the Study:

  • To highlight the synergy between TMAs and proteomics in life science research.
  • To explore the application of these technologies in understanding autoimmune diseases.
  • To discuss the potential for developing novel diagnostic and therapeutic strategies.

Main Methods:

  • Utilizing high-density tissue microarrays (TMAs) for simultaneous molecular analysis.

Related Experiment Videos

  • Employing various proteomics techniques for protein innovation and characterization.
  • Array-based antigenic fingerprinting for autoantibody profiling.

    • Main Results:

    • The combination of genomics and proteomics within tissue arrays offers a powerful approach to studying autoimmunity.
    • This integration facilitates the validation of proteomic data at the morphologic tissue level.
    • Array-based methods can drive the development of antigen-specific diagnostic tools and therapies.

    Conclusions:

    • The synergy of TMAs and proteomics is poised to revolutionize the study of autoimmune disease biology.
    • This approach holds promise for identifying novel drug targets for antigen-specific therapies.
    • Future developments may include personalized therapies based on individual patient autoantigens to induce immune tolerance.